Medication Understanding in MS
NCT07518381 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2026-04-08
Summary
The goal of this observational study is to learn how people with multiple sclerosis (MS) understand, organise, and use their medicines at home. The study aims to explore how people take their prescribed and non-prescribed medicines, what challenges they experience, and whether any safety issues arise in day-to-day medication use.
Participants will take part in one home visit with trained student researchers. During the visit, researchers will review all medicines and supplements the participant uses, ask about routines and any difficulties, check medication packaging with permission, and ask a brief question about memory. No treatment changes will be made. Information will be reviewed by a senior clinician, and any safety concerns will be shared with the participant's usual healthcare team.
Conditions
Sponsors & Collaborators
-
University Hospitals of Derby and Burton NHS Foundation Trust
collaborator OTHER -
Nottingham University Hospitals NHS Trust
collaborator OTHER -
University of Nottingham
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-15
- Primary Completion
- 2026-07-15
- Completion
- 2026-09-01
More Related Trials
-
Therapeutic Monitoring of Drugs Used in the Treatment of Multiple Sclerosis
NCT05112484 ·Status: NOT_YET_RECRUITING
-
Pharmacogenomics of Drug Safety in Multiple Sclerosis
NCT01118130 ·Status: COMPLETED
-
Baseline Cortical Haemodynamics in MS
NCT02481882 ·Status: UNKNOWN ·Phase: NA
-
Symptom Burden in Patients Treated With Ocrelizumab for Multiple Sclerosis
NCT04855617 ·Status: COMPLETED
-
Screening for Cognitive Disorders in Multiple Sclerosis
NCT07030036 ·Status: NOT_YET_RECRUITING
-
Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis
NCT05949580 ·Status: RECRUITING
-
A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
NCT00529581 ·Status: COMPLETED ·Phase: PHASE2
-
Strengthening Mental Abilities With Relational Training (SMART) in Multiple Sclerosis (MS): A Feasibility Trial
NCT04975685 ·Status: RECRUITING ·Phase: NA
-
The Use of Technology to Improve MS Clinical Trials and Patient Care
NCT02454907 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Relationship Between the Nutritional Habits and Relapsing and Disability Rates in Patient With Multiple Sclerosis.
NCT04110171 ·Status: UNKNOWN
-
Use of a Smartphone Application to Predict the Prognosis in Patients With Newly Diagnosed Multiple Sclerosis.
NCT04595799 ·Status: ACTIVE_NOT_RECRUITING
-
Digital Cognition in Multiple Sclerosis
NCT03569618 ·Status: COMPLETED ·Phase: NA
-
Study of Empathy in MS
NCT05332951 ·Status: COMPLETED
-
Digital Gait Analysis in the Home Environment of Patients With Multiple Sclerosis
NCT04771858 ·Status: COMPLETED
-
Decision Making in Multiple Sclerosis Care Under Uncertainty
NCT04035720 ·Status: UNKNOWN ·Phase: NA
-
Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS)
NCT02258217 ·Status: COMPLETED ·Phase: NA
-
A RCT of Telephone-supported ACT in MS
NCT02596633 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
NCT02792231 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Fingolimod on the Cardiac Autonomic Regulation in Patients With Multiple Sclerosis
NCT01704183 ·Status: COMPLETED
-
A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303
NCT02193217 ·Status: COMPLETED ·Phase: PHASE1
-
Prescription Drug Safety and Effectiveness in Multiple Sclerosis
NCT04472975 ·Status: COMPLETED
-
Understanding Magnetic Resonance Imaging in Multiple Sclerosis
NCT03872583 ·Status: COMPLETED ·Phase: NA
-
Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients
NCT00262314 ·Status: COMPLETED
-
A Novel Wearable Digital Biomarker for Detecting Changes in Multiple Sclerosis (MS) Condition
NCT05781113 ·Status: ACTIVE_NOT_RECRUITING
-
E-reporting of Adverse Drug Reactions by Patients in Relapsing-remitting Multiple Sclerosis
NCT03029897 ·Status: COMPLETED ·Phase: NA